Merck says Ebola vaccine to be available at lowest access price for poor nations

Merck& Co said on Friday it expects to make licensed doses of its recently approved Ebola vaccine available in the third quarter of 2020 and price the single-dose injection at the lowest possible access price for poor and middle-income countries.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news